August 8th 2023
From bug bites to poison ivy, the skin can be exposed to a large spectrum of trouble while patients spend extended time outside.
July 12th 2023
The American Skin Association estimated that 50 million Americans are exposed to urushiol yearly, the most common contact allergen in the US.
July 11th 2023
Click here to answer this week's HS poll.
July 10th 2023
Bush revealed what she is looking forward to in the coming year and the goals she wants to accomplish.
June 24th 2023
Melodie Young, MSN, ANP-c, shares pearls on why prioritizing skin checks during Psoriasis Action Month in August is critical.
New Drugs Tackle Tough Challenges
Potential game-changers in the pipeline and newly FDA-approved treatments were highlighted in an overview of new drugs to watch at Maui Derm NP+PA Fall 2021 meeting.
Nailing the Nail Diagnosis
As a part of her Maui Derm NP+PA Fall 2021 presentation, Phoebe Rich, MD, discusses how different diseases manifest in the nails, including multiple patient examples, and whether or not biopsy is needed for diagnosis.
Tips to Train NPs, PAs in Neuromodulators, Dermal Fillers
Expert panelists outline best practices to set up nurse practitioners (NPs) and physician assistants (PAs) for success in injecting neuromodulators and dermal fillers as part of the preconference track at Maui Derm NP+PA Fall 2021 .
Maui Derm NP+PA Fall Has Begun
The Maui Derm NP+PA Fall 2021 8th Annual Meeting begins today with an in-person, 4-track preconference program at the Omni Grove Park Inn in Asheville, North Carolina. Continue to check in for the next 3 days for the latest coverage of the main program which is from September 30 to October 3.
Recognizing and Treating Rosacea in Skin of Color
Hilary Baldwin, MD, presented on how to recognize, diagnose, and treat rosacea in patients with skin of color at the Skin of Color Update 2021.
Pipeline Updates in Melanoma
Possible melanoma treatments have had multiple newsworthy events since July 2021.
Climate Change Takes Toll on Skin Health
Vector-borne infectious diseases are spreading and skin cancer is rising because of climate change.
At-Home Treatment Recommendations for Keratosis Pilaris
The AAD has provided various at-home treatments for keratosis pilaris that physicians can recommend to their patients.
How to Choose Integrative AD Therapies
From oat oil to acupuncture to prebiotics, there are many topical, oral, and manual options.
Mental Health Affects Psoriatic Arthritis Treatment
Patients with anxiety/depression and psoriatic arthritis (PsA) are much less likely to achieve long-term remission. Mental health comorbidities need to be a more important part of PsA treatment.
July FDA Approvals to Watch
Explore what dermatologic drugs the FDA will decide to approve during July 2021.
First Genetic Test for Hair Loss
New TrichoTest aims to help clinicians diagnose and treat alopecia.
COVID-19 Increases Urgency of Addressing Vitamin D Deficiencies in Patients With Skin of Color
A higher prevalence of vitamin D deficiency in people of color may be contributing to a higher burden of COVID-19 in minority populations. Dermatologists are encouraged to address vitamin D status in patients and recommend supplementation, which might have other health benefits.
Secukinumab Approved for Plaque Psoriasis in Children, Adolescents
John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.
Debunking Sunscreen Controversies
Sunscreen is a necessary preventive tool. However, there are concerns about UV agent absorption, environmental impact, and possible correlations with frontal fibrosing alopecia (FFA). Here is a look at whether those worries are justified by research.
Off-label Sarecycline Combats Papulopustular Rosacea
Recent therapeutic advances in topical and systemic therapy offer new options for cases that have not responded to established treatment approaches.
Optimize Risk, Management of Pigmented Lesions in Pediatric Patients
Diagnosis, risk assessment and treatment of congenital melanocytic nevi (CMN), as well as melanoma, require specific strategies for pediatric patients.
Pathogens, Microbiota May Impact Rosacea
One expert says the action of demodex folliculorum and the composition of the symbiotic microbiota in the skin of patients with rosacea may provide valuable insights into the pathogenesis and pathophysiology of this widespread skin disease.
What Role Will Telehealth Play After COVID-19
A recent study finds that payer sway in a region hurts not only patient care, but also physician pay.
Emerging therapies beyond lasers
Next-generation therapies explore solutions other than laser treatments, and are less invasive, safer and require less downtime.
Half of patients with AD satisfied with treatment
Half of patients are satisfied with their atopic dermatitis treatment and more than half of patients worry about topical steroid side effects, addiction and withdrawal, according to a recent study.
NPF provides disease management guidance during COVID-19
The National Psoriasis Foundation’s (NPF) COVID-19 Task Force has recently published 22 guidance statements related to managing psoriatic disease during the pandemic in the Journal of American Academy of Dermatology (JAAD).
Baricitinib demonstrates long-term safety, efficacy for AD
In recently presented data at the 29th annual European Academy of Dermatology and Venereology (EADV) virtual congress, baricitinib demonstrated significant long-term safety and efficacy in treating moderate-to-severe atopic dermatitis.
Survey highlights quality of life sentiment among patients with AD
Only half of patients are satisfied with their atopic dermatitis treatment; yet, only about one-third discuss their quality-of-life concerns with their healthcare provider, a recent survey reveals.
Behavioral economics concepts guide tactics to promote patient engagement, treatment compliance
Steven R. Feldman, M.D., Ph.D., describes several tactics based on concepts from behavioral economics that can be implemented in counseling conversations with patients.
Weekly Roundup: June 22-26
ICYMI, this week’s edition features a video series on social media use in dermatology, the launch of our new podcast, as well as articles about FDA approvals for acne and cSCC, progress in epidermolysis bullosa, new rosacea management treatment, plus more.
Research gains traction for hidradenitis suppurativa
Efforts are underway to identify new therapeutic methods that can offer improved outcomes for patients with hidradenitis suppurativa.
The immunocompromised dermatology patient and COVID-19
In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.
Addressing the aesthetic needs of millennials
Dr. Suneel Chilukuri of Refresh Dermatology located in Houston, Tx., sits down with Dermatology Times to discuss the aesthetic needs of millennial patients and what they've been requesting, such as treatment for 'tech neck' and much more.
The benefits of aesthetic combination treatments
2 Clarke Drive Cranbury, NJ 08512